Results

Total Results: 1,402 records

Showing results for "adverse".

81. AHRQ Evidence-based Practice Center Program Research Gaps Summary: Primary Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
    March 01, 2022 - Serious adverse events are more common in patients who received lasmiditan than placebo. … Evidence is insufficient to draw conclusions about serious adverse events. … Evidence is insufficient to draw conclusions about serious adverse events. … pharmacologic therapy for acute pain, including any adverse event, study withdrawal due to adverse … Large increases in withdrawal due to adverse events were seen with oxcarbazepine.

82. Treatments for Schizophrenia in Adults: A Systematic (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
    January 01, 2017 - events (frequency of any adverse events reported in trials) • Withdrawals due to adverse events, time … • Significant (major) adverse events Key Question 2: • Overall adverse events (frequency of any adverse … events reported int rials) • Withdrawals due to adverse events, time to withdrawal due to adverse events … Given the variation in specific adverse event profiles across the SGAs, withdrawals due to adverse events … and ziprasidone Withdrawal Due to Adverse Events • Withdrawals due to adverse events were significantly

83. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
    September 01, 2011 - Adverse events 22 Low 1 fair trial: no significant differences in ECT + rTMS specific adverse events … VNS vs. sham Adverse events 235 Low 1 fair trial: Some differences in specific adverse events reported … Safety, Adverse Events, and Adherence (KQ 4) Direct evidence. … Specific adverse events. … More careful and consistent assessment of adverse events is required.

84. Management of Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
    June 01, 2016 - Propranolol was associated with short-term (<6 months) adverse effects such as hypotension, hypoglycemia … Minor adverse effects such as cold extremities, diarrhea, rash, and sleep changes were also reported … . ��� Timolol (topical) Adverse effects 4 353 No adverse effects were observed. ��� STEROIDS All … steroids Adverse effects 16 3291 Steroids were associated with clinically important adverse effects, … effects associated with the different interventions for IH ��Potential long-term adverse effects

85. Management of Primary Headache During Pregnancy: Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
    March 23, 2019 - events o Maternal  Serious maternal adverse events* • “Serious” adverse events (including those … events* o Fetal/infant  Serious fetal/infant adverse events* • “Serious” adverse events (including … events o Maternal  Serious maternal adverse events* • “Serious” adverse events (including those … events* o Fetal/infant  Serious fetal/infant adverse events* • “Serious” adverse events (including … ) due to neonatal/infant adverse events.

86. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
    March 01, 2011 - Key Question 3: Adverse Events and Side Effects This Key Question was addressed by 107 studies. … Other adverse events. … Some adverse effects, such as congestive heart failure, may take years to develop, and others, such as … We recommend improvements in adverse event and long-term outcome reporting, with predefined outcomes … High The rates of GI adverse effects were similar for thiazolidinediones and sulfonylureas.

87. Diagnosis and Management of Gout: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
    January 01, 2017 - = randomized controlled trial; SOE = strength of evidence; ULT = urate-lowering therapy Table 4: Adverse … �� Gastrointestinal symptoms, fatigue, and headache �� Rare adverse effects include leukopenia, aplastic … effects include bone marrow suppression, aseptic meningitis, and dermatological adverse events �� Serious … adverse effects include gastrointestinal perforations, ulcers, and increased risk of heart attack or … with the various treatment strategies ��The role of ULT in patients with gout and the potential adverse

88. Urinary-Incontinence-Treatment Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
    October 29, 2012 - events: 1 serious adverse events: The [(n/N (%)] was 6/127 (5) versus 4/120 (3); p= 0.70 Any adverse … events [(n/N (%)] 1 serious adverse events: 6/127 (5) vs. 4/120 (3); p= 0.70 Any adverse events: … Fesoterodine resulted in higher rates of adverse effects and discontinuation of treatment due to adverse … events [(n/N (%)] 1 serious adverse events: 6/127 (5) vs. 4/120 (3); p= 0.70 Any adverse events … Fesoterodine resulted in higher rates of adverse effects and discontinuation of treatment due to adverse

89. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes). … Data were insufficient for adverse events. 18 Table D. … for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes).

90. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes). … Data were insufficient for adverse events. 18 Table D. … for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes).

91. Treatments for Adults with Schizophrenia: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
    September 23, 2016 - But SGAs also have potentially serious adverse effects (e.g., cardiovascular and endocrinologic adverse … Harms Outcomes: KQ 1: § Overall adverse events (frequency of any adverse events reported in trials … events (frequency of any adverse events reported in trials) § Withdrawals due to adverse events, … ) • Significant (major) adverse events KQ 2: • Overall adverse events (frequency of any adverse events … reported in trials) • Withdrawals due to adverse events, time to withdrawal due to adverse events

92. Comparative Effectiveness Review No. 258_Diagnostic Errors in the Emergency Department: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/diagnostic-error-executive-summary.pdf
    August 01, 2023 - Some of these patients suffer an adverse event because of the incorrect diagnosis (~2.0%), and some … of these adverse events are serious (~0.3%). … This translates to about 1 in 18 ED patients receiving an incorrect diagnosis, 1 in 50 suffering an adverse … the United States that 7.4 million (5.7%) patients are misdiagnosed, 2.6 million (2.0%) suffer an adverse … average diagnostic performance, each year this would be over 1,400 diagnostic errors, 500 diagnostic adverse

93. Insomnia Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
    December 01, 2015 - Evidence on adverse effects was insufficient. … Adverse effects did not differ between groups. … Data were insufficient for adverse effects. … Withdrawals due to adverse effects, but not any specific adverse effect or overall withdrawals, were … long-term use or rare adverse effects.

94. Template for Reports Developed (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
    March 08, 2012 - Adverse local effects may include nosebleeds, stinging, burning, and dryness. … Other local adverse effects may include nosebleeds, stinging, burning, and dryness. … Local adverse effects may include nosebleeds and nasal and oral dryness. … How do adverse effects vary with intermittent or continuous use? … Table 4 lists systemic and local adverse effects of interest.

95. Migraine-Adults-Executive-130408 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
    April 01, 2013 - To assess adverse effects and treatment discontinuation due to adverse effects, we analyzed all included … Adverse Effects With Drugs for Chronic Migraine Onabotulinumtoxin A resulted in adverse effects and … Increase in risk of adverse effects was dose responsive. … Adverse Effects With Drugs for Episodic Migraine Bothersome adverse effects leading to treatment discontinuation … in trials with higher placebo rates of adverse effects.

96. Epilepsy-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - informative - There is new evidence available for KQ1 (effectiveness, health outcomes) and KQ3 (adverse … , bone density, and cosmetic adverse effects? … Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. … , bone density, and cosmetic adverse effects? … , bone density, and cosmetic adverse effects?

97. Epilepsy-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - informative - There is new evidence available for KQ1 (effectiveness, health outcomes) and KQ3 (adverse … , bone density, and cosmetic adverse effects? … Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. … , bone density, and cosmetic adverse effects? … , bone density, and cosmetic adverse effects?

98. Making Healthcare Safer IV: Summary of Findings, 2023-2024 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
    May 01, 2024 - Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug Events ........ … Reducing Adverse Drug Events Related to Anticoagulant Use in Adults 9a. … involving CDSS to reduce medication errors and adverse drug events. … Adverse Events in Hospitals: A Quarter of Medicare Patients Experienced Harm in October 2018. … Reducing Adverse Drug Events Related to Anticoagulant Use in Adults 9a.

99. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
    January 01, 2022 - Outcomes Quality of Life Outcomes Anxiety and Depression Outcomes Sleep Outcomes Opioid Use Outcomes Adverse … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse

100. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - due to any adverse event did not reach statistical significance). … , any GI adverse events (RR 0.31, 95% CI 0.24 to 0.39), and withdrawals due to GI adverse events (RR … , 95% CI 0.70 to 0.99), but there was no difference in risk of GI adverse events, withdrawal due to adverse … events, or withdrawal due to GI adverse events. … events and higher risk of dermatologic adverse compared to oral NSAIDs.